Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Public ClinicalTrials.gov record NCT04115839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the effect of filgotinib compared to placebo as assessed by the American College of Rheumatology 20% improvement (ACR20) response in participants with active psoriatic arthritis who have an inadequate response or are intolerant to biologic disease-modifying anti-rheumatic drugs (DMARD) therapy.
Study identification
- NCT ID
- NCT04115839
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 106 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2019 (Actual)
- Primary completion
- Jan 4, 2021 (Actual)
- Completion
- Mar 18, 2021 (Actual)
- Last update posted
- Mar 18, 2022
2019 – 2021
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medvin Clinical Research | Covina | California | 91723 | — |
| Omega Research Debary, LLC | DeBary | Florida | 32713 | — |
| San Marcus Research Clinic, Inc. | Miami | Florida | 33015 | — |
| Arthritis Center, Inc. | Palm Harbor | Florida | 85234 | — |
| Jefrey D. Lieberman, ND, P.C. | Decatur | Georgia | 30033 | — |
| Bluegrass Community Research, Inc. | Lexington | Kentucky | 40504 | — |
| Klein & Associates, M.D., P.A. | Hagerstown | Maryland | 21740 | — |
| Clinical Research Institute of Michigan, LLC | Saint Clair Shores | Michigan | 48081 | — |
| St. Paul Rheumatology, P.A. | Eagan | Minnesota | 55121 | — |
| Arthritis Consultants, Inc. | St Louis | Missouri | 63141 | — |
| Atlantic Coast Research | Toms River | New Jersey | 08755 | — |
| Joint and Muscle Research Institute | Charlotte | North Carolina | 28204 | — |
| Paramount Medical Research & Consulting, LLC | Middleburg Heights | Ohio | 44130 | — |
| Clinical Research Source Inc | Perrysburg | Ohio | 43551 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Arthritis Group, PC | Philadelphia | Pennsylvania | 19152 | — |
| PA Regional Center for Arthritis and Osteoporosis Research | Wyomissing | Pennsylvania | 19610 | — |
| Articularis Healthcare Inc, dba, Columbia Arthritis Center, PA | Columbia | South Carolina | 29204 | — |
| ACME Research, LLC | Orangeburg | South Carolina | 29118 | — |
| Arthritis & Osteoporosis Clinic of Brazos Valley (Drug Shipment Address) | College Station | Texas | 77845 | — |
| Southwest Rheumatology Research, LLC | Mesquite | Texas | 75150 | — |
| West Virginia Research Institute PLLC | South Charleston | West Virginia | 25309 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04115839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04115839 live on ClinicalTrials.gov.